CD59 and melanoma: Moreover, the rest of SASP-related genes recruited in our risk-scoring model including HLA-B, TPMT, ATM, CD59, TRIM21, and ASPRV1 have not been well studied in melanoma, indicating their potential of novel therapeutic target.